Bahl & Gaynor Inc. Grows Position in Nutrien Ltd. (NYSE:NTR)

Bahl & Gaynor Inc. raised its holdings in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 4.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,102 shares of the company’s stock after buying an additional 276 shares during the quarter. Bahl & Gaynor Inc.’s holdings in Nutrien were worth $331,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of NTR. American Century Companies Inc. grew its holdings in shares of Nutrien by 23.1% during the third quarter. American Century Companies Inc. now owns 201,615 shares of the company’s stock worth $12,451,000 after buying an additional 37,836 shares in the last quarter. Exchange Traded Concepts LLC grew its holdings in shares of Nutrien by 904.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 753 shares of the company’s stock worth $42,000 after buying an additional 678 shares in the last quarter. AustralianSuper Pty Ltd grew its holdings in shares of Nutrien by 11.0% in the fourth quarter. AustralianSuper Pty Ltd now owns 302,506 shares of the company’s stock valued at $17,043,000 after purchasing an additional 30,084 shares during the period. CVA Family Office LLC purchased a new stake in shares of Nutrien in the fourth quarter valued at about $57,000. Finally, Kingswood Wealth Advisors LLC purchased a new stake in shares of Nutrien in the fourth quarter valued at about $213,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Stock Up 0.6 %

Shares of NTR traded up $0.28 during mid-day trading on Wednesday, hitting $49.87. 828,964 shares of the company’s stock were exchanged, compared to its average volume of 1,882,602. The stock’s 50-day moving average is $53.48 and its 200-day moving average is $52.97. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.53 and a current ratio of 1.15. Nutrien Ltd. has a fifty-two week low of $47.86 and a fifty-two week high of $69.12. The company has a market cap of $24.67 billion, a price-to-earnings ratio of 29.18, a P/E/G ratio of 1.64 and a beta of 0.83.

Nutrien (NYSE:NTRGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.34 by $0.11. The company had revenue of $5.39 billion for the quarter, compared to analyst estimates of $5.38 billion. Nutrien had a net margin of 3.01% and a return on equity of 7.31%. On average, sell-side analysts anticipate that Nutrien Ltd. will post 3.83 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 19th. Shareholders of record on Friday, June 28th were paid a $0.54 dividend. The ex-dividend date was Friday, June 28th. This represents a $2.16 annualized dividend and a yield of 4.33%. Nutrien’s dividend payout ratio is currently 126.32%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on NTR shares. UBS Group dropped their price objective on shares of Nutrien from $67.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, July 9th. Piper Sandler dropped their price objective on shares of Nutrien from $56.00 to $55.00 and set an “underweight” rating for the company in a report on Tuesday, June 11th. Scotiabank dropped their price objective on shares of Nutrien from $67.00 to $66.00 and set an “outperform” rating for the company in a report on Monday, May 13th. Royal Bank of Canada decreased their target price on shares of Nutrien from $70.00 to $60.00 and set an “outperform” rating on the stock in a research report on Monday, July 15th. Finally, Mizuho raised shares of Nutrien from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 16th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Nutrien presently has a consensus rating of “Moderate Buy” and a consensus target price of $65.63.

Read Our Latest Stock Analysis on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.